Lv1
50 积分 2023-08-28 加入
[Expert consensus on the diagnosis and treatment of advanced non-small cell lung cancer with EGFR PACC mutations (2025 edition)]
3个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
4个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
4个月前
已完结
Claudin 18.2 as a novel therapeutic target
8个月前
已完结
Claudin‐derived peptides are internalized via specific endocytosis pathways
8个月前
已完结
Interlaboratory variation in PD-L1 positivity in non-small cell lung cancer patients: a nationwide study
8个月前
已完结
Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
8个月前
已完结
CMG901, a Claudin18.2-specific antibody-drug conjugate, for the treatment of solid tumors
8个月前
已完结
皖公网安备34019202002308
